EBITDA Margin ratio Analysis of Ligand Pharmaceuticals Incorp. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-23
Very Good EBITDA Margin
35.87
Period Ending - Dec-22
Excellent EBITDA Margin
45.53
Growth
-21.21 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-5.84
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Not Good EBITDA Margin
9.65
EBITDA Margin Analysis of Ligand Pharmaceuticals Incorp.
| Ebitda Margin Ratio of Ligand Pharmaceuticals Incorp. with value of -5.84 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of Ligand Pharmaceuticals Incorp. with value of 9.65 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
| EBITDA Margin Ratio of LGND drastically fell by -21.21 % this year. |
| EBITDA Margin Ratio with value of 728.38 was highest in Year Dec-19 in last Five Years. |
| EBITDA Margin Ratio with value of 24.06 was lowest in Year Dec-20 in last Five Years. |
| Latest EBITDA Margin Ratio with value of 35.87 is lower than Average EBITDA Margin of 175.22 in last five years. |
| Ebitda Margin of Ligand Pharmaceuticals Incorp. is negative because of negative EBITDA in Trailing Twelve Months ended on Mar-24. |
Other EBITDA Margin Related Info of LGND that may interest you.
Ligand Pharmaceuticals Incorp. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LGND | 85.05 | 83.96 | 1.30 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Mild Profitability | |
FY - Historical EBITDA Margin of Ligand Pharmaceuticals Incorp.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EBITDA Margin | 35.87 | 45.53 | 42.26 | 24.06 | 728.38 | 93.98 | 48.86 |
| Change | -21.21 % | 7.76 % | 75.65 % | -96.70 % | 675.01 % | 92.35 % | 166.48 % |
FY Chart of EBITDA Margin of Ligand Pharmaceuticals Incorp.
Note : All Data Generated at the End of Trading Hours (EOD Data)